The LXRs?agonist, 24S,25-epoxycholesterol 1,was synthesized stereoselectively (100% d.e.) in 56% overall yield from methyl hyodeoxycholanate 4 in 9 steps with des-mosterol acetate 11 as the key intermediate and the mo...The LXRs?agonist, 24S,25-epoxycholesterol 1,was synthesized stereoselectively (100% d.e.) in 56% overall yield from methyl hyodeoxycholanate 4 in 9 steps with des-mosterol acetate 11 as the key intermediate and the modified Sharpless asymmetric dihydroxylation as the key step. TheLXRa subtype selective agonist 5a,6a:24S,25-diepoxycho-lesterol 2 and the novel LXRs?ligand 5b,6b:24S,25-diepo-xycholesterol 3 were also synthesized from 1.展开更多
基金supported by the National Natural Science Foundation of China(Grant No.20072047)the State Key Laboratory of Biological Organic Chemistry in Shanghai Institute of Organic Chemistry,Chongqing Science and Technology Committee(Grant No.6617)the Third Military Medical University.
文摘The LXRs?agonist, 24S,25-epoxycholesterol 1,was synthesized stereoselectively (100% d.e.) in 56% overall yield from methyl hyodeoxycholanate 4 in 9 steps with des-mosterol acetate 11 as the key intermediate and the modified Sharpless asymmetric dihydroxylation as the key step. TheLXRa subtype selective agonist 5a,6a:24S,25-diepoxycho-lesterol 2 and the novel LXRs?ligand 5b,6b:24S,25-diepo-xycholesterol 3 were also synthesized from 1.
